02-27-2020, 10:33
Goście nie widzą linków. Zarejestruj się aby zobaczyć linki. br>
Guest cannot abble to see links, please REGISTER to see links In fact, Project CBD , a California-based nonprofit organization dedicated to analyzing and monitoring research on cannabidiol, recently wrote a resounding rejection report on this claim of liver damage, a "sensationalist statement based on a I study more than doubtful. " For starters, the University of Arkansas study did not perform real tests on humans , what Project CBD calls "an enormously important distinction." They also criticize that the mice were subjected to doses proportional to those used by humans , stating that "real-world CBD consumers do not ingest 0.25% of their body weight," the maximum dose used with the mice in the study. The criticism of Project CBD also extends to the fact that the study is full of "strange statements and an irrational experimental design." They even add that the authors underestimate the importance of positive medical findings about CBD, such as its anti-inflammatory and antioxidant properties, which are even reflected in previous studies that have also suggested that marijuana can actually help prevent liver damage in people with alcoholism . The US Food and Drug Administration. UU. It is receiving pressure from different political and social levels to regulate products containing cannabidiol. In fact, CBD derived from hemp has already been legalized at the federal level under the Agricultural Law of 2018 , but food and pharmaceutical products prepared with this compound remain technically illegal until the FDA implements the relevant regulations. Therefore, none of the CBD products currently sold throughout the US It has received FDA approval . And the only medication that has been approved, Epidiolex, apparently has a great warning of potential liver damage. In a statement published on the FDA website on June 19 "the significant public interest" of the CBD is recognized after the public hearing on the matter held on May 31 . But as an explanation for the delay in the regulations, he argues that "there are still many unanswered questions about the science, safety and quality of the products that contain this compound."
Goście nie widzą linków. Zarejestruj się aby zobaczyć linki. br>
Guest cannot abble to see links, please REGISTER to see links
Guest cannot abble to see links, please REGISTER to see links In fact, Project CBD , a California-based nonprofit organization dedicated to analyzing and monitoring research on cannabidiol, recently wrote a resounding rejection report on this claim of liver damage, a "sensationalist statement based on a I study more than doubtful. " For starters, the University of Arkansas study did not perform real tests on humans , what Project CBD calls "an enormously important distinction." They also criticize that the mice were subjected to doses proportional to those used by humans , stating that "real-world CBD consumers do not ingest 0.25% of their body weight," the maximum dose used with the mice in the study. The criticism of Project CBD also extends to the fact that the study is full of "strange statements and an irrational experimental design." They even add that the authors underestimate the importance of positive medical findings about CBD, such as its anti-inflammatory and antioxidant properties, which are even reflected in previous studies that have also suggested that marijuana can actually help prevent liver damage in people with alcoholism . The US Food and Drug Administration. UU. It is receiving pressure from different political and social levels to regulate products containing cannabidiol. In fact, CBD derived from hemp has already been legalized at the federal level under the Agricultural Law of 2018 , but food and pharmaceutical products prepared with this compound remain technically illegal until the FDA implements the relevant regulations. Therefore, none of the CBD products currently sold throughout the US It has received FDA approval . And the only medication that has been approved, Epidiolex, apparently has a great warning of potential liver damage. In a statement published on the FDA website on June 19 "the significant public interest" of the CBD is recognized after the public hearing on the matter held on May 31 . But as an explanation for the delay in the regulations, he argues that "there are still many unanswered questions about the science, safety and quality of the products that contain this compound."
Goście nie widzą linków. Zarejestruj się aby zobaczyć linki. br>
Guest cannot abble to see links, please REGISTER to see links